Company Overview and News

 
Loblaw Co.’s President’s Choice tops credit-card customer satisfaction survey

2018-09-10 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CDNTF TNTTF ACDVF CDNAF TD TD AC

 
Police search for group after 15 connected robberies in Halton, Peel and Toronto overnight

2018-08-30 cbc.ca
Police have issued a public safety advisory after a group of at least three males allegedly carried out "up to 15" robberies across the GTA overnight Thursday.
CDNTF CDNAF

 
Teen charged with first-degree murder in Toronto stabbing

2018-08-29 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CDNTF CDNAF

37
Canadian Tire: Is The Earnings Miss A Concern?

2018-08-27 seekingalpha
The company reported a weak earnings growth in Q2 2018 mostly due to severe weather condition in April.
CDNTF AMZN CDNAF CTC WMT

4
David Olive: The benefits to raising Ontario’s minimum wage are tangible

2018-08-25 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CDNTF CDNAF THI CAO

 
Aeroplan members get more certainty after deal, despite lingering questions

2018-08-22 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CDNTF ACDVF CDNAF AC

 
How Can One Sleep Hearing Holy-Inquisition-Style Sri Lankan Discourses?

2018-08-18 colombotelegraph
How can one sleep hearing holy-Inquisition-style Sri Lankan discourses? – Reply to Grusha Andrews’ wet dream on glyphosate
HD CDNTF CDNAF

 
Canadian Tire Q2 profit falls, revenue up but below analyst estimates

2018-08-09 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CDNTF CDNAF

 
Canadian Tire shares slide as Q2 profit falls, revenue below analyst estimates

2018-08-09 cbc.ca
Canadian Tire Corp.'s second-quarter profit was down compared with last year and and its revenue growth came in below analyst estimates.
CDNTF CDNAF

 
CANADA STOCKS-TSX rises as Saudi Arabia reassures Canadian oil customers

2018-08-09 reuters
Aug 9 (Reuters) - Canada’s main stock index rose on Thursday, as energy shares bounced back on higher oil prices and Saudi Arabia reassured Canada on oil supplies following an ongoing diplomatic dispute.
PXT CDNTF PARXF TREVF MFC HZM 0945 HZM CDNAF MFC

 
UPDATE 1-Canadian Tire profit falls 20 pct as investments rise

2018-08-09 reuters
Aug 9 (Reuters) - Retailer Canadian Tire Corp Ltd reported a 20 pct fall in quarterly profit on Thursday, as the company ramped up investments in its stores and online business.
CDNTF CDNAF

 
When a simple tire change becomes a debate over personal privacy

2018-08-07 cbc.ca
A Timberlea, N.S., man is questioning Canadian Tire's collection of personal information after he says he was told he must provide his vehicle permit and insurance before the business would change a tire.
CDNTF CDNAF

 
First Capital Realty Inc. (FCRGF) CEO Adam Paul on Q2 2018 Results - Earnings Call Transcript

2018-08-05 seekingalpha
First Capital Realty Inc. (OTCPK:FCRGF) Q2 2018 Earnings Conference Call August 2, 2018 2:00 PM ET
CHOO FCR.DB.H FCR.DB.I FCRGF CDNTF FCR.DB.J CDNAF FCAP JYMHF FCR FCR.DB.E

1
4 Stocks For Your Retirement Portfolio

2018-08-01 seekingalpha
Last week, I have introduced you to the 4% rule for retirees. The whole idea to work with this simple rule is to build a portfolio generating over 4% in yield with a dividend growth perspective to beat inflation (about 2%). On July 31st DSR launched 2 retirement portfolios (one 100% Canadian and another 100% US). You can learn more about them here. Each portfolio will include 20 robust and high yielding stocks.
ENB CDNTF CMQMY HP CDNAF ENB CMI

4
Meet the kinder, gentler — and Canadian — face of Tim Hortons

2018-07-31 cbc.ca
The ongoing war between some Tim Hortons' owners and their U.S.-based corporate parent is costing everyone: Sales have struggled for six straight quarters and the brand's reputation has plummeted.
CDNTF CDNAF THI QSR QSR.WI

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

6h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

CUSIP: 136681202